.png?width=150&name=MMS%20logo_without%20Tagline%20(Full%20Color).png "MMS logo_without Tagline (Full Color)")
Navigating GxP Compliance with Remote Access
By Sharon Barattini, Senior Quality and Compliance Specialist Over the past year, many professionals in ...
How to Use Machine Learning in Clinical Research
Clinical research is very complex, mainly because the questions we answer are almost always multivariate ...
EU Clinical Trials Regulation: The Need for Coordination by Sponsors
Planning, timing, and coordination. These three words may be the magic formula that Sponsors will have to ...
Why Every Pharmaceutical Company Needs to Plan for Drug Product Labeling Early in Clinical Studies
By: Victoria Woodham, Senior Medical Writer For many scientists and healthcare professionals involved ...
On-Demand Webinar: Avoiding Common Pitfalls in the IND and CTA Submission Process
Abstract: When planning an Investigational New Drug (IND) or Clinical Trial Authorization (CTA) submission , ...
3 Approaches for Quality Control in the Pharma Industry
By Jim Newman and Ravi Kishore Kandula
Why You Should Update Your Clinical Trial Disclosure Policy for the EU Clinical Trials Regulation and ICMJE Requirements Now
By Karim Ibazatene, Associate Director, Transparency
Quality Control of Regulatory Documents: Best Practices to Ensure a First-Time Quality Approach
Abstract: The concept of regulatory document quality in the pharmaceutical industry derives, in part, from ...
MMS HOLDINGS JOINS DECENTRALIZED TRIALS & RESEARCH ALLIANCE (DTRA) AS A FOUNDING MEMBER TO ACCELERATE THE ADOPTION OF PATIENT-FOCUSED CLINICAL TRIALS
CANTON, Mich. (January 29, 2021) – MMS Holdings – an award-winning, data-focused CRO – joins a historic ...
MMS Academy Launches Mobile App for Accessing Pharmaceutical Industry Virtual Learning Courses from Anywhere
CANTON, Mich. (October 28, 2020) – MMS Holdings (MMS) – an award-winning, data-focused CRO – announced today ...
FDA Advisory Committee Meeting Held to Discuss Important Topics Surrounding COVID-19 Vaccines
by Samantha Hoopes, PhD, RAC The US Food and Drug Administration’s (FDA) Vaccines and Related Biological ...
Modernizing the Functional Service Provider (FSP) Relationship: Innovations to bring value beyond “Global and Scalable”
Abstract: The Global Clinical Research Organization (CRO) market is expected to grow to $71.7 billion in ...